Overview
Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis
Status:
Terminated
Terminated
Trial end date:
2018-05-17
2018-05-17
Target enrollment:
0
0
Participant gender:
All
All
Summary
THe purpose of this study is to evaludate the Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients with GastritisPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Criteria
Inclusion Criteria:- Male of female of at least 19 years old
- Patients diagnosed with acute or chronic gastritis by gastroscopy
- Patients with one or more erosions found by gastroscopy
Exclusion Criteria:
- Patients with peptic ulcer and gastroesophageal reflux disease
- Patients with previous gastrointestinal surgery
- Patients with history of gastrointestinal cancer